Continuous Glucose Monitoring (CGM) Market to Reach USD 21 Billion by 2029, Fueled by Rising Diabetes Prevalence and Technological Innovation

Mordor Intelligence has published a new report on the Continuous Glucose Monitoring (CGM) Market, offering a comprehensive analysis of trends, growth drivers, and future projections.

The global Continuous Glucose Monitoring (CGM) Market, valued at USD 11.63 billion in 2024, is projected to surge to USD 21.32 billion by 2029, registering a CAGR of 12.89%, according to Mordor Intelligence. This growth is driven by rising diabetes rates, demand for improved disease management solutions, and technological advancements that have transformed CGM devices into essential tools for diabetes care. With the support of government initiatives and insurance coverage expansions, CGM devices are becoming increasingly accessible, making them a critical component in healthcare systems worldwide.

Report Overview - https://www.mordorintelligence.com/industry-reports/continuous-glucose-monitoring-market

Key Trends Shaping the CGM Market

1. Rising Diabetes Prevalence Propels Demand for CGM Devices

The alarming rise in diabetes cases worldwide is a significant driver for CGM market growth. According to the International Diabetes Federation, regions like Africa are projected to experience a 134% increase in diabetes cases by 2045, with North America and the Caribbean also facing substantial growth. In the United States alone, over 38 million adults were diagnosed with diabetes in 2022, with an additional 97.6 million adults diagnosed with prediabetes. These staggering numbers underscore the need for effective glucose monitoring solutions. CGM devices have proven essential for diabetes management, providing real-time insights that help patients and healthcare providers manage blood glucose levels efficiently.

2. Technological Advancements Enhance CGM Device Accessibility and Functionality

Continuous glucose monitoring technology has evolved, with innovations enhancing device accuracy, usability, and integration with other digital health platforms. Non-invasive and wearable CGM options now offer more convenient monitoring solutions, allowing individuals to track their glucose levels via smartphones and other devices. Companies are integrating artificial intelligence to improve data interpretation, enabling predictive insights that aid in personalized diabetes care. For example, Dexcom's latest CGM devices, which gained FDA clearance in early 2024, target patients with Type 2 diabetes, demonstrating how technological advances are expanding CGM accessibility across different diabetic populations.

3. Government Support and Reimbursement Expansion Boost CGM Adoption

Governments worldwide are implementing programs to combat diabetes, improving awareness and encouraging CGM adoption. In May 2023, India's Health Ministry announced a plan to screen and treat 75 million individuals with diabetes by 2025, reinforcing the importance of preventive healthcare. In the United States, initiatives like the Diabetes Learning Lab, launched by the NGA Center for Best Practices, have promoted diabetes management strategies at the state level. These programs are accompanied by expanded insurance coverage for CGM devices, enabling broader access for patients and supporting sustained market growth.

4. Emerging Markets Present Growth Opportunities

The CGM market is witnessing growing interest from emerging regions, particularly Asia-Pacific and Latin America, where diabetes rates are rising, and healthcare infrastructure is improving. Government programs in countries like China, India, and Brazil are creating favorable conditions for CGM adoption, with awareness campaigns, funding for diabetes management, and a focus on preventive healthcare measures. As these countries enhance their healthcare systems, they offer significant growth opportunities for CGM manufacturers seeking to expand their market presence globally.

Market Segmentation

The CGM market is segmented by component and geography:

By Component:

Sensors: The most critical component in CGM devices, responsible for accurately monitoring glucose levels and transmitting real-time data.

Durables: Includes receivers and transmitters, essential for data collection and display.

By Geography:

North America: The largest market due to high diabetes prevalence, advanced healthcare infrastructure, and favorable insurance coverage.

Europe: Growing demand supported by government initiatives and stringent healthcare standards.

Asia-Pacific: Fastest-growing region driven by increasing diabetes cases and healthcare infrastructure development.

Latin America and Middle East & Africa: Emerging markets with rising diabetes awareness and supportive government policies.

Get a Customized Report Tailored to Your Requirements. -

https://www.mordorintelligence.com/market-analysis/monitoring-devices

Key Players

Prominent players in the CGM market include Dexcom, Inc., Abbott Laboratories, Medtronic plc, Senseonics Holdings, Inc., and F. Hoffmann-La Roche AG. These companies lead the industry by developing cutting-edge devices that address the needs of diverse diabetic populations.

Dexcom, Inc. has made significant strides with its CGM devices tailored for different types of diabetes, improving accessibility and functionality for a broader user base.

Abbott Laboratories continues to innovate with its FreeStyle Libre range, focusing on user-friendly, cost-effective devices that enhance glucose monitoring.

Medtronic plc combines CGM devices with insulin delivery systems, providing comprehensive diabetes management solutions.

Senseonics Holdings, Inc. offers implantable CGM options, providing long-term monitoring solutions that reduce the need for frequent sensor replacements.

F. Hoffmann-La Roche AG focuses on integrated digital health solutions that allow seamless data sharing between patients and healthcare providers.

These companies leverage research and development to drive innovation, creating more accurate and user-friendly CGM devices that are integral to diabetes care. Strategic partnerships, product launches, and investments in emerging markets are among the approaches these companies use to maintain a competitive edge in the growing CGM market.

Conclusion

The Continuous Glucose Monitoring market is positioned for substantial growth, driven by the rising prevalence of diabetes, advancements in monitoring technology, and government-backed healthcare initiatives. North America and Europe lead in terms of market size due to established healthcare systems and favorable insurance policies, while Asia-Pacific offers high growth potential with its expanding healthcare infrastructure and increasing diabetes awareness. As CGM technology continues to evolve, offering more accessible, accurate, and user-friendly options, the market is expected to meet the growing needs of diabetic populations worldwide, facilitating better disease management and improved patient outcomes.

Industry Related Reports

Middle East and Africa Continuous Glucose Monitoring Market: The continuous glucose monitoring market in the Middle East and Africa is segmented by component and geography. The components include sensors and durables, while the geographic segmentation covers Saudi Arabia, Iran, Egypt, Oman, South Africa, and the rest of the Middle East and Africa.

To know more visit this link: https://www.mordorintelligence.com/industry-reports/middle-east-and-africa-continuous-glucose-monitoring-market

North America CGM Market: The report covers manufacturers and companies within the North American continuous glucose monitoring industry. The market is segmented by components, including sensors and durables, and by geography.

To know more visit this link: Source: https://www.mordorintelligence.com/industry-reports/north-america-continuous-glucose-monitoring-market

Asia Pacific Continuous Glucose Monitoring (CGM) Market: The report covers the market size and share of the Asia Pacific continuous glucose monitoring (CGM) market by company. The market is segmented by individual components, including sensors and durables (receivers and transmitters), as well as by geography.

To know more visit this link: https://www.mordorintelligence.com/industry-reports/asia-pacific-continuous-glucose-monitoring-market

For any inquiries or to access the full report, please contact:

media@mordorintelligence.com
https://www.mordorintelligence.com/

About Mordor Intelligence:

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.

With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.

This release was published on openPR.